Europe Opioid Induced Constipation (OIC) Drugs Market Analysis 2020

Published: January 2020

No. of Pages: 118

Price:

Single User License: US $ 3450 US $ 2760
Corporate User License: US $ 6800 US $ 5440

Report Description
Table of Contents

In this report, our team research the Europe Opioid Induced Constipation (OIC) Drugs market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for these regions, from 2014 to 2026 (forecast), including
- Germany
- UK
- France
- Russia
- Benelux
- Italy
- Spain

Europe Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers/players, with Opioid Induced Constipation (OIC) Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
- Ironwood Pharmaceuticals Inc
- Daiichi Sankyo Co Ltd
- Pfizer
- Progenics Pharmaceuticals Inc
- Shionogi & Co., Ltd
- Allergan Plc
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma AG
- Mundipharma International Limited
- Ono Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma Inc
- Valeant Pharmaceuticals International
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for each application, including
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Opioid Induced Constipation (OIC) Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Lubiprostone Market Performance (Volume)
2.1.2 Methyl Naltrexone Bromide Market Performance (Volume)
2.1.3 Naldemedine Market Performance (Volume)
2.1.4 Alvimopan Market Performance (Volume)
2.1.5 Other Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Lubiprostone Market Performance (Value)
2.2.2 Methyl Naltrexone Bromide Market Performance (Value)
2.2.3 Naldemedine Market Performance (Value)
2.2.4 Alvimopan Market Performance (Value)
2.2.5 Other Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospital Pharmacies Market Performance (Volume)
3.1.2 Retail Pharmacies Market Performance (Volume)
3.1.3 Online Pharmacies Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Ironwood Pharmaceuticals Inc
4.1.1 Ironwood Pharmaceuticals Inc Profiles
4.1.2 Ironwood Pharmaceuticals Inc Product Information
4.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Performance
4.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.2 Daiichi Sankyo Co Ltd
4.2.1 Daiichi Sankyo Co Ltd Profiles
4.2.2 Daiichi Sankyo Co Ltd Product Information
4.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Performance
4.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.3 Pfizer
4.3.1 Pfizer Profiles
4.3.2 Pfizer Product Information
4.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Business Performance
4.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.4 Progenics Pharmaceuticals Inc
4.4.1 Progenics Pharmaceuticals Inc Profiles
4.4.2 Progenics Pharmaceuticals Inc Product Information
4.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Performance
4.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.5 Shionogi & Co., Ltd
4.5.1 Shionogi & Co., Ltd Profiles
4.5.2 Shionogi & Co., Ltd Product Information
4.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Performance
4.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.6 Allergan Plc
4.6.1 Allergan Plc Profiles
4.6.2 Allergan Plc Product Information
4.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Performance
4.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.7 Nektar Therapeutics
4.7.1 Nektar Therapeutics Profiles
4.7.2 Nektar Therapeutics Product Information
4.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Performance
4.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.8 Purdue Pharma
4.8.1 Purdue Pharma Profiles
4.8.2 Purdue Pharma Product Information
4.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Performance
4.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.9 S.L.A. Pharma AG
4.9.1 S.L.A. Pharma AG Profiles
4.9.2 S.L.A. Pharma AG Product Information
4.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Performance
4.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.10 Mundipharma International Limited
4.10.1 Mundipharma International Limited Profiles
4.10.2 Mundipharma International Limited Product Information
4.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Performance
4.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.11 Ono Pharmaceutical Co., Ltd
4.12 Takeda Pharmaceutical Company Limited
4.13 Theravance Biopharma Inc
4.14 Valeant Pharmaceuticals International
4.15 Cosmo Pharmaceuticals SA
4.16 Daewoong Pharmaceutical
4.17 C.B. Fleet Company
4.18 Sucampo Pharmaceuticals
5 Market Performance for Manufacturers
5.1 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
5.4 Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 Germany Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 Germany Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 Germany Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 UK Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 UK Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 UK Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 France Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 France Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 France Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Russia Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Russia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Russia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Benelux Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Benelux Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Benelux Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Italy Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Italy Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Italy Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Spain Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Spain Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Spain Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Europe Opioid Induced Constipation (OIC) Drugs Market Performance (Sales Point)
7.1 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Regions 2014-2020
7.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Regions 2014-2020
7.4 Europe Opioid Induced Constipation (OIC) Drugs Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 Germany Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 UK Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 France Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Russia Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 Benelux Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Italy Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Spain Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospital Pharmacies Industry
11.2 Retail Pharmacies Industry
11.3 Online Pharmacies Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2021-2026
12.1.3 Germany Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 UK Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 France Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Russia Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Benelux Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Italy Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Spain Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Lubiprostone Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Methyl Naltrexone Bromide Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.4 Naldemedine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.5 Alvimopan Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.6 Other Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospital Pharmacies Sales and and Growth Rate 2021-2026
12.3.3 Retail Pharmacies Sales and and Growth Rate 2021-2026
12.3.4 Online Pharmacies Sales and and Growth Rate 2021-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) Trend 2021-2026
12.4.2 Europe Opioid Induced Constipation (OIC) Drugs Gross Profit Trend 2021-2026
13 Conclusion

List of Tables and Figures

Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Table Product Specifications of Opioid Induced Constipation (OIC) Drugs
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2019
Table Product Type and Standard
Table Type Overview in 2019
Table Product Application and Standard
Table Application Overview in 2019
Figure Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs
Table Industry News List of Opioid Induced Constipation (OIC) Drugs
Figure New Project SWOT Analysis of Opioid Induced Constipation (OIC) Drugs
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Types
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Types in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Types in 2019
Table Lubiprostone Sales (K Units) and Growth Rate
Figure Lubiprostone Sales (K Units) and Growth Rate
Table Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table Naldemedine Sales (K Units) and Growth Rate
Figure Naldemedine Sales (K Units) and Growth Rate
Table Alvimopan Sales (K Units) and Growth Rate
Figure Alvimopan Sales (K Units) and Growth Rate
Table Other Sales (K Units) and Growth Rate
Figure Other Sales (K Units) and Growth Rate
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) by Types
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Types in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Types in 2019
Table Lubiprostone Revenue (M USD) and Growth Rate
Figure Lubiprostone Revenue (M USD) and Growth Rate
Table Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table Naldemedine Revenue (M USD) and Growth Rate
Figure Naldemedine Revenue (M USD) and Growth Rate
Table Alvimopan Revenue (M USD) and Growth Rate
Figure Alvimopan Revenue (M USD) and Growth Rate
Table Other Revenue (M USD) and Growth Rate
Figure Other Revenue (M USD) and Growth Rate
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application 2014-2020
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2019
Table Hospital Pharmacies Sales (K Units) and Growth Rate 2014-2020
Figure Hospital Pharmacies Sales (K Units) and Growth Rate 2014-2020
Table Retail Pharmacies Sales (K Units) and Growth Rate 2014-2020
Figure Retail Pharmacies Sales (K Units) and Growth Rate 2014-2020
Table Online Pharmacies Sales (K Units) and Growth Rate 2014-2020
Figure Online Pharmacies Sales (K Units) and Growth Rate 2014-2020
Table Ironwood Pharmaceuticals Inc Profiles
Table Ironwood Pharmaceuticals Inc Product Information
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Daiichi Sankyo Co Ltd Profiles
Table Daiichi Sankyo Co Ltd Product Information
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Pfizer Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Progenics Pharmaceuticals Inc Profiles
Table Progenics Pharmaceuticals Inc Product Information
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Shionogi & Co., Ltd Profiles
Table Shionogi & Co., Ltd Product Information
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Allergan Plc Profiles
Table Allergan Plc Product Information
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Nektar Therapeutics Profiles
Table Nektar Therapeutics Product Information
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Purdue Pharma Profiles
Table Purdue Pharma Product Information
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table S.L.A. Pharma AG Profiles
Table S.L.A. Pharma AG Product Information
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Mundipharma International Limited Profiles
Table Mundipharma International Limited Product Information
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Change 2014-2020
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Market Status Change 2014-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table UK Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table UK Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure UK Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure UK Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table UK Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table UK Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure UK Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure UK Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table UK Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure UK Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure UK Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table UK Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure UK Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure UK Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure UK Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table France Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table France Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure France Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure France Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table France Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table France Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure France Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure France Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table France Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure France Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure France Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table France Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure France Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure France Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure France Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Russia Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table Russia Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Russia Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure Russia Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table Russia Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Russia Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Russia Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure Russia Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table Russia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Russia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Russia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table Russia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure Russia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure Russia Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure Russia Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Benelux Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table Benelux Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Benelux Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure Benelux Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table Benelux Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Benelux Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Benelux Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure Benelux Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table Benelux Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Benelux Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Benelux Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table Benelux Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure Benelux Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure Benelux Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure Benelux Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Italy Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table Italy Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Italy Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure Italy Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table Italy Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Italy Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Italy Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure Italy Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table Italy Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Italy Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Italy Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table Italy Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure Italy Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure Italy Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure Italy Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Spain Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table Spain Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Spain Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure Spain Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table Spain Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Spain Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Spain Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure Spain Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table Spain Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Spain Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Spain Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table Spain Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure Spain Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure Spain Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure Spain Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2014-2020
Table Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2014
Figure Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2019
Table Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2014
Figure Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2019
Table Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2019
Table Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2014-2020
Figure Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2014
Figure Opioid Induced Constipation (OIC) Drugs Gross Margin in 2019
Figure Opioid Induced Constipation (OIC) Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Regions 2014-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Regions 2014-2020
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Regions in 2014
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Regions in 2019
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) by Regions 2014-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Regions 2014-2020
Figure Europe Opioid Induced Co

Write comment about above report:

Published By: XYZResearch

Product Code: XYZResearch3124

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *